InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Lai Goldman Myla, Director. Officer active across 4 companies, notably West Pharmaceutical Services INC. Aggregated, 12 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €93k. Activity tracked since 12 June 2023. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lai Goldman Myla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
8,073 股Common StockSEC:0001168581-26-000002:0
23,372 股0Common StockSEC:0001168581-26-000001:0
2,084 股@ US$5.54100.0% 占其流量Common StockSEC:0001168581-25-000003:0
20,000 股Common StockSEC:0001062993-25-012722:0
2,940 股Common StockSEC:0001562180-25-005380:0
1,071 股0Common StockSEC:0001127602-25-013709:0
564 股0Common StockSEC:0001127602-24-013406:0
20,000 股@ US$5.00100.0% 占其流量Common StockSEC:0001104659-23-070484:0
标准退出：2023年9月10日 (T+90)
616 股Common StockSEC:0001562180-23-003696:0
632 股Common StockSEC:0001562180-22-004429:0
577 股Common StockSEC:0001562180-21-003309:0
31,085 股Common StockSEC:0001193614-16-000050:0
12 条申报中的 12 条
About Lai Goldman Myla
LAI GOLDMAN MYLA is a Director at West Pharmaceutical Services INC, Akoya Biosciences, Inc. and SEQUENOM INC. She has 8 filings in total, and across the 8 sampled filings the reported activity is mainly an attribution, with 92911 EUR of buys and 0 EUR of sells, between 2016-01-06 and 2025-05-08. The largest listed filing is for Akoya Biosciences, Inc. on 2023-06-12 for 92910.99919821888 EUR.
